Potential of Selexipag in Chronic Thromboembolic Pulmonary Hypertension Medical Therapy
Circ J
.
2020 Sep 25;84(10):1691-1692.
doi: 10.1253/circj.CJ-20-0879.
Epub 2020 Sep 9.
Authors
Takahisa Kondo
1
,
Yoshihisa Nakano
1
,
Shiro Adachi
2
Affiliations
1
Department of Advanced Medicine in Cardiopulmonary Disease, Nagoya University Graduate School of Medicine.
2
Department of Cardiology, Nagoya University Hospital.
PMID:
32908075
DOI:
10.1253/circj.CJ-20-0879
No abstract available
Publication types
Editorial
Comment
MeSH terms
Acetamides
Double-Blind Method
Humans
Hypertension, Pulmonary* / drug therapy
Japan
Pyrazines
Substances
Acetamides
Pyrazines
selexipag